C0 and C1 N-terminal Ig domains of myosin binding protein C exert different effects on thin filament activation

Samantha P. Harris, Betty Belknap, Robert E. Van Sciver, Howard D. White, Vitold E. Galkin

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Mutations in genes encoding myosin, the molecular motor that powers cardiac muscle contraction, and its accessory protein, cardiac myosin binding protein C (cMyBP-C), are the two most common causes of hypertrophic cardiomyopathy (HCM). Recent studies established that the N-terminal domains (NTDs) of cMyBP-C (e.g., C0, C1, M, and C2) can bind to and activate or inhibit the thin filament (TF). However, the molecular mechanism(s) by which NTDs modulate interaction of myosin with the TF remains unknown and the contribution of each individual NTD to TF activation/inhibition is unclear. Here we used an integrated structure-function approach using cryoelectron microscopy, biochemical kinetics, and force measurements to reveal how the first two Ig-like domains of cMyPB-C (C0 and C1) interact with the TF. Results demonstrate that despite being structural homologs, C0 and C1 exhibit different patterns of binding on the surface of F-actin. Importantly, C1 but not C0 binds in a position to activate the TF by shifting tropomyosin (Tm) to the "open" structural state. We further show that C1 directly interacts with Tm and traps Tm in the open position on the surface of F-actin. Both C0 and C1 compete with myosin subfragment 1 for binding to F-actin and effectively inhibit actomyosin interactions when present at high ratios of NTDs to F-actin. Finally, we show that in contracting sarcomeres, the activating effect of C1 is apparent only once low levels of Ca2+ have been achieved.We suggest that Ca2+ modulates the interaction of cMyBP-C with the TF in the sarcomere.

Original languageEnglish (US)
Pages (from-to)1558-1563
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume113
Issue number6
DOIs
StatePublished - Feb 9 2016
Externally publishedYes

Fingerprint

Cardiac Myosins
Tropomyosin
Actins
Sarcomeres
Myosins
Cryoelectron Microscopy
Myosin Subfragments
Actomyosin
Hypertrophic Cardiomyopathy
Muscle Contraction
Myocardium
Mutation
myosin-binding protein C
Immunoglobulin Domains
Genes
Proteins

Keywords

  • Actin
  • Cryo-EM
  • Muscle regulation
  • Myosin binding protein C
  • Tropomyosin

ASJC Scopus subject areas

  • General

Cite this

C0 and C1 N-terminal Ig domains of myosin binding protein C exert different effects on thin filament activation. / Harris, Samantha P.; Belknap, Betty; Van Sciver, Robert E.; White, Howard D.; Galkin, Vitold E.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, No. 6, 09.02.2016, p. 1558-1563.

Research output: Contribution to journalArticle

Harris, Samantha P. ; Belknap, Betty ; Van Sciver, Robert E. ; White, Howard D. ; Galkin, Vitold E. / C0 and C1 N-terminal Ig domains of myosin binding protein C exert different effects on thin filament activation. In: Proceedings of the National Academy of Sciences of the United States of America. 2016 ; Vol. 113, No. 6. pp. 1558-1563.
@article{5f5fef1aedaa4b8bb7ea3e70df346676,
title = "C0 and C1 N-terminal Ig domains of myosin binding protein C exert different effects on thin filament activation",
abstract = "Mutations in genes encoding myosin, the molecular motor that powers cardiac muscle contraction, and its accessory protein, cardiac myosin binding protein C (cMyBP-C), are the two most common causes of hypertrophic cardiomyopathy (HCM). Recent studies established that the N-terminal domains (NTDs) of cMyBP-C (e.g., C0, C1, M, and C2) can bind to and activate or inhibit the thin filament (TF). However, the molecular mechanism(s) by which NTDs modulate interaction of myosin with the TF remains unknown and the contribution of each individual NTD to TF activation/inhibition is unclear. Here we used an integrated structure-function approach using cryoelectron microscopy, biochemical kinetics, and force measurements to reveal how the first two Ig-like domains of cMyPB-C (C0 and C1) interact with the TF. Results demonstrate that despite being structural homologs, C0 and C1 exhibit different patterns of binding on the surface of F-actin. Importantly, C1 but not C0 binds in a position to activate the TF by shifting tropomyosin (Tm) to the {"}open{"} structural state. We further show that C1 directly interacts with Tm and traps Tm in the open position on the surface of F-actin. Both C0 and C1 compete with myosin subfragment 1 for binding to F-actin and effectively inhibit actomyosin interactions when present at high ratios of NTDs to F-actin. Finally, we show that in contracting sarcomeres, the activating effect of C1 is apparent only once low levels of Ca2+ have been achieved.We suggest that Ca2+ modulates the interaction of cMyBP-C with the TF in the sarcomere.",
keywords = "Actin, Cryo-EM, Muscle regulation, Myosin binding protein C, Tropomyosin",
author = "Harris, {Samantha P.} and Betty Belknap and {Van Sciver}, {Robert E.} and White, {Howard D.} and Galkin, {Vitold E.}",
year = "2016",
month = "2",
day = "9",
doi = "10.1073/pnas.1518891113",
language = "English (US)",
volume = "113",
pages = "1558--1563",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "6",

}

TY - JOUR

T1 - C0 and C1 N-terminal Ig domains of myosin binding protein C exert different effects on thin filament activation

AU - Harris, Samantha P.

AU - Belknap, Betty

AU - Van Sciver, Robert E.

AU - White, Howard D.

AU - Galkin, Vitold E.

PY - 2016/2/9

Y1 - 2016/2/9

N2 - Mutations in genes encoding myosin, the molecular motor that powers cardiac muscle contraction, and its accessory protein, cardiac myosin binding protein C (cMyBP-C), are the two most common causes of hypertrophic cardiomyopathy (HCM). Recent studies established that the N-terminal domains (NTDs) of cMyBP-C (e.g., C0, C1, M, and C2) can bind to and activate or inhibit the thin filament (TF). However, the molecular mechanism(s) by which NTDs modulate interaction of myosin with the TF remains unknown and the contribution of each individual NTD to TF activation/inhibition is unclear. Here we used an integrated structure-function approach using cryoelectron microscopy, biochemical kinetics, and force measurements to reveal how the first two Ig-like domains of cMyPB-C (C0 and C1) interact with the TF. Results demonstrate that despite being structural homologs, C0 and C1 exhibit different patterns of binding on the surface of F-actin. Importantly, C1 but not C0 binds in a position to activate the TF by shifting tropomyosin (Tm) to the "open" structural state. We further show that C1 directly interacts with Tm and traps Tm in the open position on the surface of F-actin. Both C0 and C1 compete with myosin subfragment 1 for binding to F-actin and effectively inhibit actomyosin interactions when present at high ratios of NTDs to F-actin. Finally, we show that in contracting sarcomeres, the activating effect of C1 is apparent only once low levels of Ca2+ have been achieved.We suggest that Ca2+ modulates the interaction of cMyBP-C with the TF in the sarcomere.

AB - Mutations in genes encoding myosin, the molecular motor that powers cardiac muscle contraction, and its accessory protein, cardiac myosin binding protein C (cMyBP-C), are the two most common causes of hypertrophic cardiomyopathy (HCM). Recent studies established that the N-terminal domains (NTDs) of cMyBP-C (e.g., C0, C1, M, and C2) can bind to and activate or inhibit the thin filament (TF). However, the molecular mechanism(s) by which NTDs modulate interaction of myosin with the TF remains unknown and the contribution of each individual NTD to TF activation/inhibition is unclear. Here we used an integrated structure-function approach using cryoelectron microscopy, biochemical kinetics, and force measurements to reveal how the first two Ig-like domains of cMyPB-C (C0 and C1) interact with the TF. Results demonstrate that despite being structural homologs, C0 and C1 exhibit different patterns of binding on the surface of F-actin. Importantly, C1 but not C0 binds in a position to activate the TF by shifting tropomyosin (Tm) to the "open" structural state. We further show that C1 directly interacts with Tm and traps Tm in the open position on the surface of F-actin. Both C0 and C1 compete with myosin subfragment 1 for binding to F-actin and effectively inhibit actomyosin interactions when present at high ratios of NTDs to F-actin. Finally, we show that in contracting sarcomeres, the activating effect of C1 is apparent only once low levels of Ca2+ have been achieved.We suggest that Ca2+ modulates the interaction of cMyBP-C with the TF in the sarcomere.

KW - Actin

KW - Cryo-EM

KW - Muscle regulation

KW - Myosin binding protein C

KW - Tropomyosin

UR - http://www.scopus.com/inward/record.url?scp=84957837407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957837407&partnerID=8YFLogxK

U2 - 10.1073/pnas.1518891113

DO - 10.1073/pnas.1518891113

M3 - Article

C2 - 26831109

AN - SCOPUS:84957837407

VL - 113

SP - 1558

EP - 1563

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 6

ER -